Longitudinal panel data analysis examines anonymity's effect on self-disclosure in illness stages, suggesting nuanced identity management strategies.
Objective This study examines how anonymity influences self-disclosure and social feedback across illness stages, and whether these effects vary with disease progression. To theorize these dynamics, we propose a Dynamic Identity Management (DIM) framework to visualize how anonymity shapes self-disclosure and social feedback, and whether these effects vary with disease progression. Methods We collected posts from the “Cancer” super-topic on Zhihu between January 2018 and January 2024 using Python web crawlers. Through semantic embedding (Sentence-BERT) and clustering (similarity threshold=0.8), we linked anonymous posts to their real-name authors, constructing a six-year longitudinal panel dataset of 1,998 posts from 215 users. User and year fixed-effects models were employed to estimate the causal effects of anonymity on disclosure motivation, emotional expression, information breadth and sensitivity, and social feedback (likes and comments), with illness stage (initial diagnosis, mid-stage, terminal) as a moderator. Results Anonymity significantly increased intrinsic disclosure motivation ( β =−0.318, p <.01) and negative emotional expression ( β =−0.196, p <.05), but did not affect social feedback or factual information disclosure. Both initial and terminal stages directly increased social feedback (likes and comments, p <.001) and negative emotional expression ( p <.001) compared to the mid-stage. Illness stage significantly moderated anonymity’s effects: the negative effect of anonymity on comments was stronger during initial ( β =−0.334, p <.05) and terminal stages ( β =−0.313, p <.05); its facilitative effect on negative emotional expression was amplified in both critical stages (initial: β =−0.258, p <.05; terminal: β= −0.265, p <.05); and its positive effect on intrinsic motivation was attenuated during these high-stakes phases (initial: β= 0.297, p< .05; terminal: β= 0.357, p <.05). Conclusion Anonymity selectively facilitates intrinsic motivation and negative emotional expression but does not increase social feedback or factual information disclosure. Users dynamically manage identity across the illness stage: in high-risk stages (initial diagnosis and terminal), they prioritize emotional release through anonymity, even though this reduces social feedback relative to real-name posting; in the low-risk mid-stage, they use anonymity for intrinsically motivated disclosure without losing social feedback. This pattern supports the DIM framework’s proposition: anonymity is not a fixed personal attribute; its effects depend on the illness stage. By specifying this dynamic mechanism, the DIM framework advances understanding of anonymity in OHCs and offers actionable insights for designing stage-sensitive health support systems.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: